TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 104 filers reported holding TG THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,912 | -65.9% | 15,779 | -38.7% | 0.04% | -69.0% |
| Q1 2023 | $387,069 | +62.6% | 25,736 | +53.8% | 0.13% | +117.2% |
| Q1 2018 | $238,000 | +52.6% | 16,738 | +8.0% | 0.06% | +7.4% |
| Q2 2017 | $156,000 | +81.4% | 15,500 | -16.7% | 0.05% | +20.0% |
| Q4 2016 | $86,000 | – | 18,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |